Used in Suzuki-Miyaura cross-coupling reactions to synthesize pharmaceutical intermediates and agrochemicals. Its boronic acid group enables efficient carbon-carbon bond formation, particularly in the development of bioactive molecules containing trifluoromethylated pyridine rings. The electron-withdrawing trifluoromethyl group enhances metabolic stability in drug candidates, making this compound valuable in medicinal chemistry for creating more potent and durable therapeutic agents. Also applied in the preparation of functional materials and ligands for catalysis.